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ABSTRACT 
Objectives. To dissect the role of TLR signaling and B cell survival/proliferating factors in 
the cross-talk between rheumatoid synovial fibroblasts (RASF) and B cells.   
Methods. RASF, RA dermal fibroblasts (RADF) and SF from OA patients (OASF), were 
analysed for the expression of B cell survival/proliferating factors BAFF and APRIL in 
resting conditions and upon stimulation with TLR2/TLR3/TLR4 ligands. Un-switched IgD+ 
B cells were co-cultured with RASF/OASF/RADF in the presence/absence of TLR ligands 
and with/without BAFF/APRIL blocking antibodies. AID mRNA expression, Iγ-Cμ and Iα-
Cμ circular transcripts (CTs, markers of ongoing class-switching to IgG and IgA) and 
IgM/A/G production were measured to assess functional activation of B cells. 
Results. TLR3 and to a lesser extent TLR4, but not TLR2 stimulation induced up to ~1000-
fold BAFF mRNA and increased soluble BAFF release. APRIL was less significantly 
regulated by TLR3. Resting and TLR3-stimulated RASF released higher levels of 
BAFF/APRIL compared to RADF. TLR3 stimulation of RASF but not RADF in co-culture 
with B cells strongly enhanced AID expression, Iγ-Cμ and Iα-Cμ CTs and class-switching to 
IgG/IgA. Blockade of BAFF/APRIL signaling completely inhibited TLR3-induced RASF-
dependent expression of AID, CTs and the secretion of IgG/IgA. 
Conclusions. RASF produce high levels of BAFF and APRIL constitutively and in response 
to TLR3 stimulation. These factors are critical in directly modulating AID expression, CSR 
and IgG/IgA production in IgD+ B cells. Overall, we highlight a novel and fundamental role 
for the TLR3/B cell survival factor axis in sustaining B cell activation in the RA synovium.
INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic autoimmune/inflammatory disease characterised by 
immune cell infiltration in the synovial tissue leading to cartilage destruction and bone 
erosion[1]. One of the hallmarks of RA is a dysregulated activation of autoreactive B cells, 
leading to the production of autoantibodies such as rheumatoid factor (RF) and anti-
citrullinated protein antibodies (ACPA), which are important diagnostic and prognostic 
markers and are implicated in disease pathogenesis[2]. The critical relevance of B cells in RA 
pathogenesis is demonstrated by the clinical effectiveness of B cell depletion[3,4]. However, 
the cellular and molecular mechanisms regulating autoreactive B cell activation in RA are 
poorly understood. We and others have shown that RA synovial tissues with ectopic 
lymphoid structures (ELS), characterised by perivascular aggregates of T and B cells with the 
differentiation of follicular dendritic cells (FDC) networks[5,6], represent functional niches 
of autoreactive B cell activation and differentiation. In particular, ELS promote the 
expression of activation-induced cytidine deaminase (AID), the enzyme required for somatic 
hypermutation (SHM) and class-switch recombination (CSR) of the Ig genes, triggering 
synovial B cells to undergo in situ differentiation towards autoreactive plasma cells[7,8]. 
ELS+ RA synovia engrafted into severe combined immunodeficient (SCID) mice sustain 
AID expression, B cell survival and proliferation, ongoing CSR and production of ACPA in 
the absence of re-circulating immune cells[8], suggesting that resident synovial cells are 
critically involved in regulating humoral autoimmunity in RA. B cell functionality in the 
SCID/RA model is critically dependent on the B cell survival and proliferating factors BAFF 
and APRIL[8,9], although the source of these factors in the synovial microenvironment is 
unclear.  
RA fibroblast-like synoviocytes (RASF) share properties of FDC in rescuing B cells from 
apoptosis and promoting their proliferation and differentiation into antibody-producing 
cells[10-14]. However, the mechanisms regulating the cross-talk between RASF and B cells 
are unclear. Recent evidence demonstrated that B cells can be directly activated to undergo Ig 
class-switching in the presence of BAFF and APRIL released at mucosal sites by epithelial 
cells sensing pathogens via Toll-like receptors (TLR), particularly TLR3[15,16]. RASF can 
express high levels of BAFF and APRIL[17,18], although the effective capacity of these 
factors in supporting AID expression and ongoing CSR is unclear. In addition, although 
accumulating evidence suggests that the activation state of RASF is critically dependent on 
the expression of TLRs[19-21], the relationship between TLRs and BAFF/APRIL expression 
in RASF is controversial[19-21]. 
In the present work we investigated the effect of TLR2/3/4 ligands in modulating 
BAFF/APRIL expression in RASF and their role in promoting AID expression and CSR in 
un-switched IgD+ B cells.  
MATERIALS AND METHODS 
 
Synovial tissue collection 
Synovial tissues were obtained from patients undergoing total knee/hip replacement. A total 
of 6 RA and 8 OA samples were available at QMUL and used for isolation of synovial 
fibroblasts. Samples were collected after informed consent (LREC07/Q0605/29 granted by 
the East London & The City Research Ethics Committee 3). Matched synovial and skin 
fibroblasts from 5 RA patients undergoing total knee/hip replacement were obtained from the 
University of Birmingham (LREC5735), as previously reported[22]. All RA patients 
(10F/1M, mean age 64.1 yrs, 82% RF positive) fulfilled the American College of 
Rheumatology criteria for the classification of RA[23] and had long-standing disease 
requiring joint replacement. All patients had received DMARDs (in monotherapy or 
combination) and 2 patients received anti-TNF therapy. Patients had discontinued treatment 
before surgery for an appropriate washout period. Patients with OA had advanced disease and 
were all diagnosed with primary OA.  
 
Generation of fibroblast-like synoviocytes from RA and OA patients 
RASF and OASF were obtained as previously described[24]. After discarding fat and dense 
fibrous tissues, synovium was minced, mashed under 70-μm nylon mesh cell strainer (Becton 
Dickinson) and digested overnight at 37°C with 1.5mg/ml Dispase II in DMEM 
supplemented with 10% FCS, 50 IU/mL penicillin-streptomycin, 10 mM HEPES buffer 
(Gibco/Invitrogen)]. The resulting suspension was passed through cell strainer, centrifuged 
and the cell pellet re-suspended in culture medium and incubated in T75 tissue-culture flasks. 
When 90% confluent SF were passaged 1/3 using 0.25% trypsin/EDTA (Sigma, UK). 
Synoviocytes were used between passages 4-8 when the culture is devoid of contaminating 
lymphocyte and macrophages[25]. 
Purification of un-switched IgD+ human B cells 
Human B cells were immunomagnetically selected from tonsils obtained following routine 
tonsillectomy. Tonsils were washed with chilled (4oC) MACS buffer [PBS, 0.5% FCS and 
2mM EDTA], minced and gently mashed through a cell strainer. Cells were washed, 
centrifuged and incubated with 0.5μg/106 cells of an anti-IgD biotinylated antibody (Southern 
Biotechnologies) for 30 min on ice. After washing, cells were incubated with anti-biotin 
MicroBeads (Miltenyi Biotec) for 15 min at 4oC, washed and passed through magnetic 
separation columns (MS; Miltenyi Biotec). The effluent was collected as flow through (FT) 
fractions and the bead-bound cells (after-sorted, AS) were collected as enriched, positively 
selected IgD+ B cells. All sorting procedures were performed under sterile conditions. The 
purity of IgD+ unswitched B cell isolation was checked by FACS (Supplementary Figure 1). 
 
TLR stimulation of RASF, OASF and RADF  
Fibroblasts were seeded into 24-well plates at 4x104 cells/well and stimulated at 90% 
confluence with optimal concentrations of TLR2-4 ligands [19] (300ng/ml of bacterial 
lipopeptide (bLP), 10µg/ml of polyinosinic:polycytidylic acid (PIC) (InvivoGen), 100ng/ml 
of lipopolysaccharide (LPS) from Escherichia coli J5 (Sigma) or left untreated. Supernatants 
were harvested after the allocated time period, centrifuged and stored at -20oC until tested. 
For RNA extraction, adherent fibroblasts were rinsed with PBS and lysed in RLT buffer.  
 
Co-cultures of B cells with RASF, OASF and RADF 
Fibroblasts were seeded into 24-well plates (4 x 104 cells/1 ml/well) and used for co-culture 
experiments at 90% confluence. In cell-cell contact experiments, IgD+ B cells (1x106 
cells/300µl/well) were added onto the fibroblast layer with or without 10µg/ml PIC. In 
transwell experiments, microporous PET cell inserts (1-µm pore, Beckon Dickinson) were 
employed. B cells were grown in the upper well and PIC treated or untreated fibroblasts were 
grown on the base of the well. Control co-cultures received no fibroblasts in order to 
investigate baseline expression in isolated IgD+ B cells. Co-cultures were kept for 24h, 72h 
or 8 days, depending on the experimental conditions after which cell-free supernatants and B 
cells were collected. For gene expression profiling, pelleted B cells were lysed in RLT buffer 
(Qiagen). 
 
Blockade of BAFF/APRIL signaling on B cells with anti-BCMA and anti-BAFFR 
neutralizing antibodies 
BAFF/APRIL dependent signalling in B cells was blocked using neutralizing polyclonal goat 
anti-human BAFFR and anti-human BCMA antibodies (R&D Systems) at 10µg/ml alone or 
in combination, 30 min before co-culture and throughout the experiment. After 72h or 8 days 
of co-culture, supernatants and cells were harvested as described above. 
 
Gene expression analysis by quantitative real-time PCR (QT-PCR)  
Total RNA was isolated using the RNeasy Mini kit (Qiagen). RNA (500ng) was reverse 
transcribed to cDNA using the Thermoscript RT-PCR System (Invitrogen). For gene 
expression profiling QT-PCR was performed on cDNAs using specific TaqMan primers and 
probes [8] (Applied Biosystems, Supplementary Table 1). Taqman QT-PCR was run in 
triplicate with 10ng/well at 40 cycles of amplifications in an ABI 7900HT Instrument. 
Human 18S and human Β-actin were used as endogenous controls. Relative quantification 
was measured using the Comparative CT (Threshold Cycle) Method. 
 
Detection of circular transcripts (CTs) by polymerase-chain reaction (PCR) 
Detection of Iγ1/2-Cμ and Iα-Cμ CTs were performed as previously described with minor 
modifications [8] using 0.5U of Taq polymerase (MP biomedicals)/20µl reaction volume. 
Primers sequences and PCR conditions are summarized in Supplementary Table 2. After final 
extension at 72°C for 5 min, PCR products were run on 1% agarose gel/0.5μg/ml ethidium 
bromide in TAE buffer and visualised under UV light.    
ELISA 
BAFF and APRIL protein concentration in cell-free supernatants was measured using the 
Quantikine Human BAFF/BLyS/TNFSF13B (R&D Systems) and Human APRIL 
(eBioscience) ELISA kits respectively, following the manufacturers’ instructions. 
Total IgA, IgG and IgM were detected using the Human IgA/IgG/IgM ELISA quantitation set 
(Bethyl laboratories) according to manufacturer’s instruction. 
 
Detection of BAFF and APRIL expression in fibroblasts using immunocytochemistry 
Fibroblasts were seeded at 5x104 cells/200µl onto cover slides and grown to 90% confluence. 
Cells were then stimulated with 10µg/ml PIC or left untreated. After 24h, cells were washed 
in PBS and fixed using ice-cold 1:1 acetone/methanol. After washing in TBS and blocking 
with avidin-biotin blocking kit (Vector laboratory) and DAKO serum-free protein block, rat 
anti-human BAFF (Buffy-2, Enzo Life Sciences), mouse anti-human APRIL (Aprily-2, Enzo 
Life Sciences) or isotype controls at 10μg/ml were applied for 1h at RT. After washing, 
biotinylated donkey anti-rat (Serotec) or rabbit anti-mouse (Dako) antibodies were added for 
1h at RT. After washing, slides were incubated for 30min with Streptavidin-ALEXA555 or 
Streptavidin-FITC (1:300 dilution) and counterstained with DAPI. Slides were examined 
under Olympus BX60 microscope. 
 
Statistical Analysis 
Differences in quantitative variables were analysed by the Mann Whitney U test when 
comparing 2 groups and by Kruskal-Wallis with Dunn’s post test when comparing multiple 
groups. Wilcoxon’s signed-rank test was used to analyse repeated measurements at different 
time-points. All analyses were performed using GraphPad Prism version 5.01, GraphPad 
Software, USA. A p value <0.05 was considered statistically significant. 
RESULTS 
 
TLR3-stimulated induction of BAFF and APRIL mRNA in RASF, OASF and RADF 
We first examined whether TLR stimulation of RASF and OASF (to dissect disease 
specificity) and paired RADF (to investigate site specificity) induced BAFF and APRIL 
mRNA. At baseline, RASF and OASF displayed increased expression of BAFF mRNA, 
between 4 and 8-fold higher than RADF (data not shown), as previously reported[17]. BAFF 
mRNA expression in RASF and OASF was markedly induced by PIC (Figure 1a, e), whilst 
there was a more modest induction with LPS and no upregulation with bLP. PIC triggered a 
rapid induction of BAFF transcripts at 4h, which peaked at 8h and gradually decreased 
afterwards. A comparable increase in BAFF mRNA was induced by PIC in RADF (Figure 
1c). Interestingly, RADF produced significantly higher levels of BAFF mRNA in response to 
TLR4 stimulation as compared to RASF or OASF, and similar to that obtained with PIC.  
In comparison with BAFF, APRIL was significantly but more modestly modulated by TLR3 
stimulation in RASF and OASF (~3-fold increase) (Figure 1b, f) with no apparent modulation 
in RADF (Figure 1d), and was characterised by a later peak of induction at 24h. We finally 
investigated whether there was a differential expression of TLR3 mRNA in RASF compared 
to RADF and we found no difference among these cells in basal TLR3 expression 
(Supplementary Figure 3).  
 
 
RASF but not RADF release high levels of BAFF in response to TLR3 stimulation  
 
We next examined whether TLR3-induced BAFF mRNA was mirrored by increased protein 
expression. As shown in Figure 2a, high amounts of soluble BAFF were released in the 
supernatant of RASF in a time-dependent manner and were significantly increased upon PIC 
stimulation, (Figure 2a). Similar levels were observed in the supernatant of OASF (data not 
shown). Despite strong up-regulation of BAFF mRNA, RADF produced only modest amount 
of soluble BAFF in resting conditions and in response to PIC.  
We next investigated the intracellular localization of BAFF upon TLR3 stimulation by 
immunofluorescence. As shown in Figure 2b, weak and granular perinuclear BAFF 
immunoreactivity was detected in untreated permeabilized RASF. Upon incubation with PIC 
a strong increase in cytoplasmic BAFF (Figure 2b) as well as membrane-bound BAFF 
(Supplementary Figure 4) was observed. Similar data were observed in OASF (data not 
shown). In contrast, following exposure to PIC, BAFF expression remained barely detectable 
in RADF. Overall, these data indicate that increased production of BAFF, at basal level or 
upon TLR3 stimulation, is characteristic of SF but not DF. 
 
RASF but not RADF constitutively produce large amounts of APRIL  
We next investigated the ability of RASF and RADF to release APRIL in resting and 
stimulated conditions. Unlike RADF, RASF produced abundant basal levels of soluble 
APRIL, reaching ~900pg/ml on day 3 (Figure 3a) which was only marginally increased upon 
TLR3 stimulation (Figure 3a). However, APRIL was released at a higher rate within the first 
24h in PIC-stimulated RASF. Again, similar results were observed in OASF (data not 
shown). In contrast to RASF, APRIL levels in RADF were extremely low in basal conditions 
and remained low following TLR3 activation. Immunofluorescence staining for APRIL 
demonstrated that while resting RASF expressed an intense perinuclear and cytoplasmic 
immunoreactivity (Figure 3b), likely corresponding to vesicle-sequestered or Golgi-
associated APRIL [26], RADF were characterised by a significantly weaker staining. Overall, 
our findings indicated that RASF, but not RADF, retain the capacity to release constitutively 
high levels of APRIL which are modestly increased upon TLR3 stimulation. 
 
TLR3 stimulation of RASF, but not RADF, enhances class-switched immunoglobulin 
secretion from IgD+ human B lymphocytes 
We next examined whether TLR3 stimulation enhanced the capacity of RASF to promote Ig 
production in B lymphocytes[12] and whether this ability was dependent on direct cell-cell 
interactions and/or soluble factors.  
Tonsil IgD+ un-switched B cells at 97% purity (Supplementary Figure 1) were co-cultured 
either in cell-cell contact or in a transwell system with RASF, OASF or RADF. As shown in 
Figure 4, IgD+ B cells alone produced low amounts of IgG and IgA (Figure 4a). Conversely, 
co-culture of B cells with RASF induced a 2-3 fold increase in IgG production already at 72h 
which was significantly increased upon TLR3 stimulation (Figure 4a). Similar, albeit more 
modest induction of IgA was also evident. Paired RADF did not induce IgG or IgA 
production either in resting or stimulated conditions (Figure 4b), while OASF displayed a 
similar behaviour compared to RASF (data not shown). Interestingly, CSR to IgG/IgA still 
occurred (albeit with slightly lower efficiency) when B cells were cultured in transwells 
(Figure 4a), indicating that soluble factors released by RASF are sufficient to promote CSR. 
Treatment of RASF with PIC minimally modulated IgM production, suggesting that RASF 
induced functional B cell activation and not simply increased survival/proliferation, as 
indicated by the increased IgG/IgM ratio after 8 days compared to 24h and 72 h (Figure 5d).  
 
TLR3-stimulated RASF induce up-regulation of AID and circular transcripts in B cells 
A formal demonstration of the capacity of RASF to induce class-switching require evidence 
of AID expression and the appearance of circular transcripts (CTs). RASF strongly induced 
AID mRNA after 24 and 72h of coculture in cell-cell and transwell systems, a capacity 
further enhanced upon TLR3 stimulation (Figure 5a, b). IgD+ B cells alone (Figure 5a, b) or 
cultured with RADF (data not shown) displayed no or barely detectable levels of AID 
mRNA. The specificity of the AID and endogenous control PCR products were confirmed by 
agarose gel electrophoresis (Supplementary Figure 2c). In order to confirm that AID was 
functional, we determined the presence of Iγ1/2-Cµ CTs, specific by-products of ongoing CSR 
from IgM to IgG1/2 in B cells, which disappear 48h after CSR[27]. While no Iγ1/2-Cµ CTs 
were detected in IgD+ B cells alone at 72h, co-culture with unstimulated RASF was 
sufficient to induce CTs expression which was clearly enhanced upon TLR3 stimulation 
(Figure 5c, top gel, lane 4). RASF-dependent induction of  Iγ1/2-Cµ CTs and IgG production 
was similar to that observed using recombinant BAFF and IL4 (Supplementary Figure 2).   
Overall, these data provide conclusive evidence that RASF directly induce the expression of 
AID and the molecular machinery required for ongoing CSR in un-switched B cells and that 
TLR3 stimulation enhances this effect. 
 
Dual blockade of BAFFR and BCMA abrogates TLR3-induced AID expression and class-
switching  
We finally investigated whether the activating capacity of RASF in B cells in response to 
TLR3 was dependent on BAFF and/or APRIL. By using neutralising antibodies against 
BAFFR (specific for BAFF) and BCMA (binding both BAFF and APRIL) we showed that in 
the transwell system individual receptor blocking displayed significant but partial inhibition 
of TLR3-dependent IgG and IgA production, while the combination of anti-BAFFR/anti-
BCMA completely suppressed TLR3-induced IgG and IgA production (Figure 6a). In 
addition, blockade of BAFFR/BCMA down-regulated AID expression and the production of 
Iγ1/2-Cµ CTs (Figure 6 b-c respectively). Experiments in cell-cell contact displayed similar 
results, although the inhibitory effect was slightly smaller (data not shown). Overall, these 
findings suggest that CSR induced in IgD+ B cells by RASF via TLR3 stimulation is mostly 
dependent on the production of BAFF and APRIL and can be blocked by receptor 
interference. 
DISCUSSION 
In situ autoreactive B cell activation and autoantibody production within the RA synovium is 
a typical feature of RA patients in which synovitis is characterised by the formation of 
ectopic lymphoid structures (ELS). Within RA lymphoid aggregates, B lymphocytes undergo 
antigen-driven affinity maturation, clonal expansion, Ig isotype switching and plasma cell 
differentiation[7,28,29]. We recently showed that these processes i) require the expression of 
AID, the enzyme responsible for the initiation of SHM and CSR of the Ig genes, ii) are self-
sustained for several weeks in the SCID/RA chimeric model in the absence of recirculating 
immune cells and iii) develop in the context of prolonged expression of the B cells survival 
and proliferating factors BAFF and APRIL[8]. The functionality of synovial B cell follicles is 
dependent on the interaction with networks of stromal cells which express CD21[5,6] and 
closely resemble FDC in secondary lymphoid organs[30]. Accordingly, the diffuse form of 
synovitis, characterised by the absence of B cell aggregates, lacks AID expression and 
ongoing Ig class-switching[8]. Despite strong evidence that ELS support the production of 
autoantibodies within the RA synovium, we and other demonstrated that circulating 
autoantibodies in RA do not associate with the presence of synovial ELS [8,31,32], 
suggesting that secondary lymphoid organs are also important sites for autoreactive B cell 
activation. 
Although it is currently unclear whether synovial FDC differentiate from resident stromal 
cells[33], fibroblast-like synoviocytes isolated from the RA synovium (RASF) are able to 
rescue B cells from apoptosis and promote their differentiation into antibody-producing 
cells[10-13,34,35]. However, the critical factors regulating these interactions have not been 
fully investigated. Cell-dependent mechanisms involving adhesion molecules (i.e. VCAM-1) 
and chemokines such as CXCL12 only partially account for the observed B cell 
activation[10], suggesting a critical contribution of additional factors. In addition, because 
previous work did not differentiate between naïve, switched and unswitched memory B cells 
in co-culture experiments, the actual capacity of RASF to induce the molecular machinery 
required for Ig class-switching in naïve B cells was questionable.  
In this work, we provide novel observations which contribute to our understanding of the 
mechanisms regulating the cross-talk between RASF and B cells within the RA synovium. 
First, we demonstrated that RASF constitutively produce large amount of BAFF and APRIL, 
expanding recent evidence of over-expression of these factors at mRNA level in 
RASF[17,18,36]. Furthermore, we showed that TLR3 stimulation induced strong and rapid 
up-regulation of BAFF at both mRNA and protein level while APRIL was more modestly 
modulated and displayed a delayed kinetic of expression, peaking 24-48h post-stimulation. 
Interestingly, soluble BAFF levels in resting and TLR3-activated RASF were comparable to 
those released by dendritic cells and airway epithelial cells, which express biologically 
functional amounts of BAFF upon TLR3 triggering[37-39]. Similarly, in this work we 
provided the first demonstration that RASF constitutively release high levels of soluble 
APRIL. Although, TLR3 activation did not induce a large increase in the amount of APRIL 
produced by RASF, APRIL was released at higher rate within the first 24h, possibly 
reflecting a role for TLR3 in the early mobilization of intracellular APRIL. Furthermore, 
APRIL was not homogeneously expressed among RASF, demonstrating some heterogeneity 
within the RASF population. 
Despite RASF over-express TLR4[19], LPS treatment induced only limited levels of BAFF, 
similar to airway fibroblasts[40]. These results are in keeping with previous evidence that 
TLR4 can even down-regulate BAFF mRNA expression in RASF in the presence of 
IFNγ[21] and confirm that BAFF transcription is under the control of TRIF (Toll/IL-1R 
domain-containing protein inducing IFN-β) rather than MyD88-dependent pathways. 
Importantly, the capacity of synoviocytes to respond to TLR3 by releasing high levels of 
BAFF/APRIL was not restricted to RASF as OASF displayed similar expression in resting 
and stimulated conditions. Conversely, RADF produced negligible amounts of BAFF/APRIL 
and failed to significantly increase protein expression despite similar mRNA responses to 
TLR3. Overall, this suggests that the over-expression of BAFF and APRIL in SF is 
dependent on epigenetic abnormalities related to the anatomical localization rather than 
disease specificity[22]. In addition, the importance of TLR3 is relevant to RA pathogenesis as 
RASF can be activated in the synovial microenvironment by RNA released by necrotic cells 
[24]. Importantly, because TLR3 signals via the adaptor molecule TRIF in a MyD88-
independent pathway, its activation also leads to type I IFN and IFN-responsive genes 
expression. In this regard, increase in IFNβ, which is known to be upregulated in the RA 
synovium [41], might contribute to the pathogenesis of RA by exacerbating Th17, as recently 
suggested [42].  
RASF were extremely efficient compared to RADF in inducing the prompt and sustained 
production of class-switched antibodies, primarily IgG and to a lesser extent IgA from 
unswitched IgD+ B cells. Stimulation of RASF (and OASF), but not RADF, with TLR3 
ligands strongly enhanced the production of IgG and IgA in co-cultured B cells, an effect 
directly dependent on RASF as IgD+ B cells alone did not respond to PIC.  
The process of isotype class-switching requires AID and occurs via excision of switch circles 
following the introduction of double strand DNA breaks in the Ig switch regions[43]. 
Accordingly, we showed that RASF, but not RADF, induced a rapid and sustained de novo 
expression of AID in co-cultured IgD+ B cells, an effect significantly potentiated by TLR3 
simulation. Subsequently, we demonstrated that AID expression induced Iγ-Cμ CTs, which 
are a sensitive marker of class-switching, being transiently produced for up to 48h after 
CSR[27]. Thus, increased detection of Iγ-Cμ CTs after over 72h of co-culture demonstrated 
that class-switching from IgM to IgG was actively ongoing and that TLR3 stimulation of 
RASF potentiated CSR in IgD+ B cells. Accordingly, the IgG/IgM ratio was over 10-fold 
higher 8 days after co-culture in TLR3-stimulated conditions as compared to 24h. Of 
relevance, TLR3-induced RASF-dependent B cells activation was maintained when B cells 
and RASF were separated via a cell insert, suggesting that soluble factors are sufficient to 
induce B cell activation. Thus is of particular importance as BAFF can elicit its biological 
functions both in a membrane-bound and a soluble form[44]. 
BAFF and APRIL are critically involved in promoting functional B cell activation, AID 
expression and Ig class switching[16,45], thus we finally questioned whether RASF-derived 
BAFF and APRIL were required to mediate these processes. We showed that TLR3-
dependent IgG and IgA production was completely inhibited after interfering with signaling 
through both BAFFR and BCMA on the B cell surface. Of relevance, only minimal effects on 
IgM production was observed, suggesting that reduced B cell activation rather than survival 
was responsible for the down-regulation of IgG/IgA. Accordingly, BAFFR/BCMA blockade 
also down-regulated the expression of AID and the production of Iγ-Cμ CTs. These in vitro 
data support in vivo observations in the RA/SCID model, in which functional niches of 
autoreactive B cells required BAFF and APRIL for Ig production[8], AID expression, 
ongoing class-switching and production of ACPA antibodies[8]. 
In summary, in this study we report that i) RASF, but not RADF, constitutively release high 
levels of BAFF and APRIL; ii) BAFF, and to a lesser extent APRIL are induced by TLR3 
ligands, iii) TLR3 stimulation enhances the capacity of RASF to promote AID expression, 
isotype class-switching and IgG/IgA production in unswitched IgD+ B cells; iv) these effects 
can be efficiently blocked by inhibition of BAFF/APRIL signalling through their receptors on 
the B cell membrane. Overall, this work contributes to elucidate the mechanisms regulating 
the cross-talk between stromal and B cells in the synovial microenvironment and highlights 
the importance of the BAFF/APRIL system in sustaining the functionality of synovial niches 
of autoreactive B cells, with potential implications for biological treatments targeting B cell-
related pathways in RA. 
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Figure Legends 
 
Figure 1. Induction of BAFF and APRIL mRNA in RASF, RADF and OASF in 
response to TLR ligands. 
Quantitative Taqman real-time PCR analysis of BAFF and APRIL mRNA expression in 
response to TLR ligands. RASF (a, b), RADF (c, d) and OASF (e, f) were stimulated with 
10µg/ml PIC (TLR3), 100ng/ml LPS (TLR4), 300ng/ml bLP (TLR2) or medium alone for 4, 
8, 24, 48, 72h.  Results are expressed as mean ± SEM of the mRNA fold increase calculated 
at each time point by setting the baseline unstimulated expression as 1. Data were normalized 
using mammalian 18S as an endogenous control gene (18S). * p<0.05, **p<0.01 compared to 
unstimulated 
 
Figure 2. TLR3 stimulation induces intracellular and soluble BAFF in RASF but not 
RADF.  
(a) Column-bar graph showing the amount of soluble BAFF released in the cell culture 
supernatant from RASF and RADF conditioned for 24, 48, 72 h in the presence or absence of 
10μg/ml PIC. RASF produce significantly higher amount of BAFF both in resting and 
stimulated conditions as compared to RADF. Results are represented as mean ± SEM of 
minimum 3 experiments. 
 (b) Representative microphotographs of BAFF immunostaining on RASF and RADF before 
and after stimulation with PIC. RASF/RADF were grown on coverslips and processed for 
immunofluorescence as described in the Methods. Nuclei are counterstained in blue (DAPI) 
and BAFF in red (Alexa-555). Primary RASF/RADF were left untreated (medium only) or 
stimulated for 24 h with PIC (10μg/ml). Appropriate isotype control was used to confirm 
specificity. Images were captured at 20X magnification and with the same exposure time for 
both conditions. 
 
Figure 3. Intracellular and soluble APRIL expression in RASF vs RADF.  
(a) Column-bar graph showing the amount of soluble APRIL released in the cell culture 
supernatant from RASF and RADF conditioned for 24, 48, 72 h in the presence or absence of 
10μg/ml PIC. Data are presented as mean ± SEM of at least 3 experiments.  
(b) Representative microphotographs of APRIL immunostaining on RASF and RADF in 
resting conditions. RASF/RADF were grown on coverslips and processed for 
immunofluorescence as described in the Methods. Nuclei are counterstained in blue (DAPI) 
and APRIL is stained in green (Alexa-488). Appropriate isotype control was used to confirm 
specificity. Images were captured at 20X magnification and with the same exposure time for 
both conditions. 
 
Figure 4. TLR3 stimulation of RASF but not RADF enhances their capacity to promote 
the production of class switched antibodies in IgD+ B cells.  
Purified tonsillar IgD+ B cells were cultured with fibroblasts for 72h. B cells were cultured 
alone (open bars) or in co-culture fibroblasts in direct physical contact (grey bars) or a 
transwell system (black bar). All cultures were incubated with (+) or without (-) 10μg/ml 
PIC. IgG, IgA and IgM levels in supernatants were measured by ELISA. Results are 
presented as mean ± SEM of at least 3 experiments. * p<0.05, **p<0.01 compared to 
unstimulated 
 
 
Figure 5. TLR3 stimulation of RASF enhances AID expression and ongoing class 
switching in co-cultured IgD+ tonsillar B cells.  
(a-b) Purified tonsillar IgD+ B cells were cultured with RASF for 24 h (a) and 72 h (b) with 
10μg/ml PIC or left untreated in the presence (transwell) of absence (cell-cell contact) of a 
cell insert. AID mRNA expression was determined by QT-PCR normalized to an endogenous 
control gene (18S) and the fold difference relative to baseline expression was calculated by 
setting AID expression in B cell alone as 1. * p<0.05, **p<0.01 compared to unstimulated 
 (c) Representative 1% agarose gel (inverted colour) of Iγ-Cµ circular transcripts (CT, 
amplicon 502 bp, upper gel), specific by-products of ongoing class-switching from IgM to 
IgG. The lower gel represents the endogenous control, mammalian 18S (amplicon 187bp). 
CTs were amplified from B cell cDNA using specific primers (Methods). B cells were 
cultured alone or in transwell with RASF for 72 h in the presence or absence of 10μg/ml PIC. 
Tonsil was used as a positive control.  
(d) Progressive production of IgG over IgM in B cells co-cultured in transwell with TLR3-
stimulated RASF after 24h, 72h and 8 days, demonstrating. Data are presented as mean IgG 
to IgM ratio ± SEM of at least 3 experiments per time point. * p<0.05, **p<0.01 compared to 
unstimulated 
.  
Figure 6. Blockade of BAFFR and/or BCMA reverses TLR-3 induced RASF-dependent 
IgD+ B cell activation.  
(a) IgG, IgA and IgM production by tonsillar IgD+ B cells cultured in transwell with RASF 
for 72 h in the presence of 10μg/ml of either anti-human BCMA or anti-human BAFF-R 
blocking antibodies or the two combined. Suppression of IgG and IgA production is 
expressed as the percentage of reduction of the effect induced by TLR3 stimulation. * 
p<0.05, **p<0.01 compared to PIC stimulated. 
 (b) Modulation of AID mRNA expression in B cells co-cultured in transwell with RASF for 
72h after blockade of BAFFR and/or BCMA signalling. Results are expressed as mean ± 
SEM of the mRNA fold increase calculated by setting the baseline expression as 1. * p<0.05, 
**p<0.01 compared to PIC stimulated.  
(c) Representative 1% agarose gel (inverted colour) of Iγ-Cµ circular transcripts (CT, 
amplicon 502 bp, upper gel) expression in B cells co-cultured in transwell with RASF for 72h 
after blockade of BAFFR and/or BCMA signalling. Endogenous control, mammalian 18S 
(amplicon 187bp) is shown in the lower gel. 
 
 
  
 
 
 
 
 
 
 
 






